Zicam 1 Tablet DT contains Clonazepam 1mg, a benzodiazepine class medication primarily indicated for the management of seizure disorders, panic disorders, and anxiety. Clonazepam acts by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby exerting anticonvulsant, anxiolytic, muscle relaxant, and sedative effects. Zicam 1 Tablet DT is formulated as a dispersible tablet, facilitating rapid dissolution and absorption, which is beneficial for patients who have difficulty swallowing conventional tablets. The standard dosage and duration of treatment should be individualized based on the patient’s clinical condition, response to therapy, and tolerability. Common adverse effects may include drowsiness, dizziness, fatigue, and coordination disturbances; patients should be cautioned against operating heavy machinery or driving until they understand how the medication affects them. Abrupt discontinuation is discouraged due to the risk of withdrawal symptoms, including seizures; tapering under medical supervision is recommended. Zicam 1 Tablet DT should be used with caution in patients with a history of substance abuse, respiratory insufficiency, or hepatic impairment. It is contraindicated in individuals with hypersensitivity to benzodiazepines and should be avoided during pregnancy and lactation unless deemed essential by a healthcare provider.